The dose-dependent effects of alcohol, where the initial euphoric and stimulant effects initiated by the exposure to low ethanol levels can quickly lead to a deadly consequence are well established. Thus, high blood alcohol concentration (BAC), as seen in alcoholics, can cause significant damage to various organs. At low concentrations (e.g., 10 mg% or lower), however, beneficial effects of alcohol, particularly on cardiovascular function have been reported. Although, the latter assertion has been challenged by recent epidemiological studies, protective effects of low alcohol concentrations in vitro and in vivo relevant to the central nervous system (CNS) is well documented. In this review, the mechanism(s) leading to the detrimental effects of high BAC, as well as the beneficial effects of low BAC will be discussed. In addition, gender consideration is touched upon. Although further investigation is clearly warranted, it may be concluded that at least some of the beneficial outcomes of low BAC, including possible neuroprotection and antidepressant-like effects, may be due to elevation of the neurotropic factors and reduction of inflammatory mediators, whereas detrimental outcomes associated with high BAC, including neurotoxicity and depressive-like behavior may be due to reduction in neurotropic factors and elevation of inflammatory mediators. Furthermore, new research strategies are suggested.

Department of Anatomy Howard University College of Medicine 520 W Street NW Washington DC 20059 USA

Department of Microbiology Howard University College of Medicine 520 W Street NW Washington DC 20059 USA

Department of Pharmacology Faculty of Medicine Masaryk University Kamenice 5 62500 Brno Czech Republic

Department of Pharmacology Howard University College of Medicine 520 W Street NW Washington DC 20059 USA

Inst de Fisiología Celular Universidad Nacional Autónoma De México Ciudad de México Mexico

Zobrazit více v PubMed

Front Behav Neurosci. 2017 Feb 07;11:15 PubMed

Neurotoxicology. 2004 Jan;25(1-2):193-204 PubMed

Biochem Pharmacol. 2002 Mar 1;63(5):909-20 PubMed

J Neurosci Res. 2017 Jan 2;95(1-2):328-335 PubMed

Neuropsychopharmacology. 2017 Aug;42(9):1776-1788 PubMed

Biol Psychiatry. 2018 Jan 1;83(1):29-37 PubMed

Neurobiol Dis. 2008 Sep;31(3):316-26 PubMed

Genes Brain Behav. 2018 Mar;17(3):e12424 PubMed

Front Behav Neurosci. 2017 Nov 28;11:233 PubMed

Prog Mol Biol Transl Sci. 2016;137:41-85 PubMed

Brain Res. 2014 Oct 24;1586:162-72 PubMed

Neuroscience. 2013 Dec 19;254:324-34 PubMed

Addict Biol. 2015 Jan;20(1):38-42 PubMed

J Clin Psychiatry. 2001;62 Suppl 20:32-41 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):177-188 PubMed

Neuroscience. 2015 Nov 19;309:113-24 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):760-8 PubMed

Life Sci. 2004 May 21;75(1):107-17 PubMed

Alcohol Clin Exp Res. 2011 Aug;35(8):1529-33 PubMed

Cell Death Differ. 2005 Oct;12(10):1329-43 PubMed

Neuroscience. 2013 Jun 3;239:149-56 PubMed

Alcohol Alcohol. 2017 Jul 1;52(4):403-413 PubMed

J Stud Alcohol Drugs. 2017 May;78(3):387-388 PubMed

Neurotox Res. 2017 Jul;32(1):8-13 PubMed

Int J Mol Sci. 2015 Dec 21;16(12):30422-37 PubMed

Nonlinear Dynamics Psychol Life Sci. 2012 Jan;16(1):79-90 PubMed

Neurotox Res. 2012 Jan;21(1):57-69 PubMed

Dialogues Clin Neurosci. 2014 Mar;16(1):11-27 PubMed

Neuropharmacology. 2016 Mar;102:72-9 PubMed

Neurotox Res. 2018 Feb;33(2):474-484 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):217-226 PubMed

JAMA Psychiatry. 2013 Sep;70(9):983-9 PubMed

J Neuroimmune Pharmacol. 2015 Dec;10(4):595-609 PubMed

Nat Rev Neurosci. 2016 Aug;17(8):497-511 PubMed

Mayo Clin Proc. 2014 Mar;89(3):382-93 PubMed

Mol Psychiatry. 2016 Jan;21(1):80-8 PubMed

Clin Psychopharmacol Neurosci. 2014 Aug;12(2):83-93 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):503-514 PubMed

Neurotox Res. 2013 Feb;23(2):131-44 PubMed

J Drug Alcohol Res. 2013 Jul 1;2:235709 PubMed

Curr Drug Targets. 2013 Oct;14(11):1329-35 PubMed

Autoimmun Rev. 2015 Jan;14(1):30-5 PubMed

Brain Struct Funct. 2016 Dec;221(9):4691-4703 PubMed

Psychopharmacology (Berl). 2016 May;233(9):1543-57 PubMed

Clin Epigenetics. 2017 Oct 23;9:117 PubMed

Alcohol Res. 2013;35(2):155-73 PubMed

Alcohol Clin Exp Res. 1999 Oct;23(10):1571-9 PubMed

Int J Mol Sci. 2017 May 18;18(5):null PubMed

Vitam Horm. 2017;104:197-242 PubMed

Front Behav Neurosci. 2017 Aug 14;11:151 PubMed

Neurosci Bull. 2017 Feb;33(1):28-40 PubMed

Neurosci Biobehav Rev. 2016 May;64:12-34 PubMed

J Drug Alcohol Res. 2017;6:null PubMed

Psychopharmacology (Berl). 1999 May;144(2):151-7 PubMed

Lancet. 1992 Jun 20;339(8808):1523-6 PubMed

J Neurosci. 2017 Feb 1;37(5):1139-1155 PubMed

Brain Res. 2015 Dec 2;1628(Pt A):68-81 PubMed

Pharmacol Rep. 2014 Oct;66(5):776-81 PubMed

Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):443-67 PubMed

J Neural Transm (Vienna). 2017 Dec;124(12):1515-1527 PubMed

Neurosci Biobehav Rev. 2015 Dec;59:1-15 PubMed

Psychiatry Investig. 2012 Mar;9(1):8-16 PubMed

Trends Pharmacol Sci. 2017 Jun;38(6):501-502 PubMed

Metab Brain Dis. 2009 Mar;24(1):27-53 PubMed

CNS Neurosci Ther. 2014 Oct;20(10):898-904 PubMed

Drug Alcohol Depend. 1985 Aug;15(4):305-22 PubMed

Cell Mol Neurobiol. 2018 Apr;38(3):579-593 PubMed

Handb Clin Neurol. 2014;125:561-71 PubMed

Alcohol. 2017 May;60:95-101 PubMed

Front Physiol. 2016 Jul 27;7:312 PubMed

Int J Mol Sci. 2016 Sep 20;17(9):null PubMed

Front Neurosci. 2015 Feb 12;9:35 PubMed

Neurotox Res. 2016 Jul;30(1):1-13 PubMed

Neural Regen Res. 2017 Jan;12(1):7-12 PubMed

J Neuroinflammation. 2017 Apr 20;14(1):86 PubMed

Neurotox Res. 2011 Oct;20(3):263-9 PubMed

Alcohol Clin Exp Res. 2004 Dec;28(12):1805-13 PubMed

PLoS One. 2017 Nov 2;12(11):e0187217 PubMed

Trends Pharmacol Sci. 2017 Jun;38(6):556-568 PubMed

Nature. 2014 Jun 5;510(7503):58-67 PubMed

Mol Neurobiol. 2017 Oct;54(8):5883-5893 PubMed

J Alcohol Drug Depend. 2014 May;2(2):148 PubMed

Am J Psychiatry. 1997 Jul;154(7):948-57 PubMed

Addict Biol. 2018 Mar;23(2):810-823 PubMed

Neurosci Biobehav Rev. 2017 May;76(Pt B):336-362 PubMed

Ann Gen Psychiatry. 2015 Sep 23;14:30 PubMed

Nat Med. 2013 Jul;19(7):934-8 PubMed

Pharmacol Biochem Behav. 2011 Dec;100(2):253-8 PubMed

Pharmacol Biochem Behav. 2018 Jan;164:50-61 PubMed

Drug Alcohol Depend. 2017 Nov 1;180:86-92 PubMed

Pharmacol Ther. 2008 Apr;118(1):36-57 PubMed

Arch Gen Psychiatry. 2002 Sep;59(9):794-800 PubMed

Alcohol Clin Exp Res. 2010 Jan;34(1):46-50 PubMed

Addict Behav. 2013 Jul;38(7):2295-305 PubMed

Autophagy. 2014;10(12):2099-108 PubMed

Psychopharmacology (Berl). 2017 May;234(9-10):1483-1498 PubMed

Neurobiol Aging. 2015 Feb;36(2):845-56 PubMed

Alcohol Clin Exp Res. 2017 Dec;41(12):2066-2081 PubMed

Neurotox Res. 2014 Oct;26(3):230-9 PubMed

Addict Biol. 2017 Nov;22(6):1829-1841 PubMed

Nat Med. 2017 Sep 8;23(9):1015-1017 PubMed

Acta Neuropathol. 2017 Mar;133(3):463-483 PubMed

Int J Environ Res Public Health. 2010 Apr;7(4):1540-57 PubMed

Neuropharmacology. 2017 Aug 1;122:148-160 PubMed

BMJ. 1996 Mar 23;312(7033):731-6 PubMed

Neuropharmacology. 2017 Aug 1;122:3-21 PubMed

Neuroscience. 2013 Aug 29;246:199-229 PubMed

Drug Alcohol Depend. 2017 Dec 1;181:200-207 PubMed

Neuroimmunomodulation. 2014;21(2-3):123-30 PubMed

Curr Pharm Des. 2014;20(23):3812-47 PubMed

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Jun;159(2):208-14 PubMed

J Neural Transm (Vienna). 2005 Nov;112(11):1583-90 PubMed

BMC Psychiatry. 2017 Apr 28;17(1):153 PubMed

Lancet Psychiatry. 2016 Aug;3(8):760-73 PubMed

Behav Brain Sci. 2011 Dec;34(6):293-310 PubMed

Immunol Allergy Clin North Am. 2009 May;29(2):309-20 PubMed

Alcohol. 2017 May;60:7-18 PubMed

J Drug Alcohol Res. 2017;6:null PubMed

J Stud Alcohol Drugs. 2017 May;78(3):375-386 PubMed

Brain Res Dev Brain Res. 2004 Jul 19;151(1-2):99-109 PubMed

Stroke. 2003 May;34(5):1246-51 PubMed

Biomed Res Int. 2014;2014:932757 PubMed

Alcohol. 2014 Nov;48(7):671-6 PubMed

Pharmacol Rev. 2016 Apr;68(2):242-63 PubMed

Neurosci Lett. 2018 Feb 14;666:175-180 PubMed

Handb Clin Neurol. 2014;125:477-97 PubMed